Pi2 heads for the great outdoors
15 October, 2002 by Iain ScottSydney-based company Pi2 Limited has touted a new business strategy with two acquisitions, one in life sciences and the other in outdoor advertising.
AstraZeneca plans for growth in Qld natural products centre
15 October, 2002 by Pete YoungPharmaceutical company AstraZeneca plans to augment the Queensland-based natural product research centre in which it has invested $55 million since 1993.
Biota braces for showdown with 'corporate rationaliser'
14 October, 2002 by Pete YoungThe scene has been set for a possible showdown next month between the board of drug discovery company Biota Holdings and Perth businessman Farooq Khan.
Mattick resigns from Benitec board
09 October, 2002 by Melissa TrudingerThe co-director of Queensland's Institute for Molecular Bioscience>, Prof John Mattick, has resigned from his position on Benitec's board of directors while he is in Germany on a sabbatical.
CSIRO sackings rumours prompt warnings
02 October, 2002 by Pete YoungReported plans to sack up to 26 staff from CSIRO's Division of Land and Water have touched off warnings about the organisation's long-term health from Federal Opposition and union sources.
Personal flavour to Lemberg Medal win
02 October, 2002 by Iain ScottThe 2002 ASBMB Lemberg Medal has special significance for its recipient, Prof Philip Board of the Australian National University.
More than 1200 new projects funded in latest ARC round
02 October, 2002 by Iain ScottA total of 1252 new projects are to receive Australian Research Council (ARC) funding, totalling $289.5 million over the next three years, it was announced today.
Better believe it - science isn't natural
30 September, 2002 by Iain ScottIt was, as he admitted himself, an unusual topic with which to kick off a cell biology meeting. But Prof Lewis Wolpert's plenary lecture, 'The Biology of Belief', which he gave at the ComBio 2002 meeting in Sydney this morning, straddled clinical research, anthropology, ancient history and technology -- setting the tone for the breadth of research that was to come at the conference.
Over 1000 in attendance for ComBio kick-off
30 September, 2002 by Iain ScottMore than 1000 delegates have rolled up for this year's ComBio conference at Sydney's Darling Harbour, according to organisers.
Iatia MD Cussinet resigns
26 September, 2002 by Melissa TrudingerThe resignation of Iatia managing director Philippe Cussinet will not impact the growth of the company, according to CEO Brian Powell.
AusBiotech to probe industry's insurance woes
25 September, 2002 by Melissa TrudingerRumours that biotechnology companies are finding it hard to renew professional indemnity insurance policies have led industry association AusBiotech to investigate the potential for problems.
VC tax reforms could assist biotech
25 September, 2002 by Pete YoungThe Federal government is implementing changes to venture capital tax structures which carry positive long-term implications for biotech companies seeking risk capital.
Lack of vision critical: FASTS report
24 September, 2002 by Graeme O'NeillAustralia's peak council for science and technology delivered a state-of-the-nation report to Federal Parliament this week that shows Australia slipping further off the pace among industrialised nations in its performance in science, technology and higher education.
Feds to fine-tune science blueprint
24 September, 2002 by Graeme O'NeillOnly 18 months into its $2.9 billion Backing Australia's Ability program, the Federal government is looking to adjust its innovation blueprint -- and that could involve culling some elements that aren't working, Science Minister Peter McGauran has foreshadowed.
Weak spots exposed by commercialisation survey
20 September, 2002 by Pete YoungA landmark survey of the commercialisation track record by Australia's publicly-funded research bodies shows worrying weak spots in a generally favourable picture.
